Nasopharyngeal swabs are often referred to as upper respiratory specimens and are traditional means of taking a sample for COVID-19 diagnosis. To perform the nasopharyngeal swab, a swab is inserted in the nose horizontally, along an imaginary line between the nostril and the ear. The global Nasopharyngeal Swabs market is projected to grow at a CAGR of 2.1% during the forecast period (2021-2027). The nasopharyngeal swabs are the most commonly used sample type for COVID-19 diagnosis and therefore, the rising numbers of COVID-19 cases are anticipated to make a huge contribution towards the growth of this market. Further, the increased focus of the country government on lifting lockdown restrictions in order to minimize economic losses in various regions across the globe have been reopened due to which testing has increased rapidly; which is another major factor that propels the growth of the global nasopharyngeal swabs market in the upcoming years.

However, the unavailability of swabs in huge quantities, the high need for personnel protective equipment while taking the sample, along the rising utility of other alternatives may restrain the demand of this market segment. Another major limitation of the nasopharyngeal swabs is, that, this technique in some cases might leads to bleeding or other discomforts; which challenges the growth of the market. 

Segmental Outlook

The global Nasopharyngeal Swabs market is segmented on the basis of product type and end-user. Based on the product type, the market is segmented as foam tipped swabs, non-woven swabs, and others. Based on the end-user, the market is segmented as hospitals & clinics, diagnostic centers, and others. 

Foam Tipped Nasopharyngeal Swabs Segment Holds a Significant Market Share 

Amongst the product type segment of the global nasopharyngeal swabs, the foam tipped swabs segment is projected to hold the most lucrative share in the market. The segmental growth of the market is accredited to the increased demand for foam tipped nasopharyngeal swabs due to the rising cases of COVID-19 across the globe. A growing number of companies have entered the global nasopharyngeal swabs market, especially in 2020, to curb the rising demand for the foam tipped nasopharyngeal swabs due to the rising demand for the same from across the world. Hence, increased demand for the foam tipped swabs owing to their ease of use is likely to aid the segmental growth of the market during the forecast period. 

Global Nasopharyngeal Swabs Market, by Product Type 2020 (%)

Regional Outlook

The global Nasopharyngeal Swabs market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region is projected to hold a significant market share. China, India, Japan, and the Rest of the Asia-Pacific are the major economies primarily contributing to the growth of the Nasopharyngeal Swabs market in the region. The regional growth of the market is accredited to the rising screening test in emerging economies. China was the first economy that was severely hit by COVID-19 as the country was the epicenter of the COVID-19. Also, the key companies are expanding their businesses to the untapped regions in emerging economies such as India and China, which further supports the growth of the market. Besides, the support of the government by promoting and enhancing the rapid testing procedures across the region is also likely to drive the nasopharyngeal swabs market growth in the region. Further, the North American region is also estimated to witness a significant value for the market, attributing to the presence of major medical devices players across the region.

Global Nasopharyngeal Swabs Market, by Region 2020 (%)

Market Players Outlook

The prominent players functioning in the global nasopharyngeal swabs market include C. R. Bard, Inc., COPAN Diagnostics, Inc., Miraclean Technology Co., Ltd., Quidel Corp., Thermo Fisher Scientific, Inc., Titan Biotech Ltd., and Trinity Biotech among others. These key manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and many others in order to thrive in a competitive environment. For instance, in January 2021, P&G partnered with Rhinostics for the innovation of novel nasopharyngeal swabs to meet the growing demand for the medical product for COVID-19 testing. Such activities and partnerships done by the major players operating in the market are likely to drive the growth of the market during the forecast period. 

The Report Covers

• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global nasopharyngeal swabs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.